IL-33/Regulatory T-Cell Axis Suppresses Skin Fibrosis
- 25 March 2022
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (10) , 2668-2676.e4
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Howard Hughes Medical Institute
- NIAMS (K08AR068619, R01AR076013)
- Burroughs Wellcome Fund
- American Heart Association
- National Research Foundation of Korea (NRF-2019R1A6A3A03031609)
This publication has 46 references indexed in Scilit:
- Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic FibrosisImmunity, 2013
- IL-33: A Novel Danger Signal System in Atopic DermatitisJournal of Investigative Dermatology, 2012
- Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung diseaseArthritis Research & Therapy, 2011
- Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosisClinical Rheumatology, 2011
- Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoeaBritish Journal of Dermatology, 2010
- IL-33 Induces IL-13–Dependent Cutaneous FibrosisThe Journal of Immunology, 2009
- Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGFβ ExpressionPLOS ONE, 2009
- IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling systemJournal of Clinical Investigation, 2007
- B-Lymphocyte Depletion Reduces Skin Fibrosis and Autoimmunity in the Tight-Skin Mouse Model for Systemic SclerosisThe American Journal of Pathology, 2006
- Lymphocytes in the skin of patients with progressive systemic sclerosisArthritis & Rheumatism, 1984